SB33-1193 Screening compound: N-[(3S,4R)-1-(4-methoxy-3-methylbenzyl)-4-(3-methyl-1H-1,2,4-triazol-5-yl)tetrahydro-1H-pyrrol-3-yl]benzamide

SB33-1193 Screening compound: N-[(3S,4R)-1-(4-methoxy-3-methylbenzyl)-4-(3-methyl-1H-1,2,4-triazol-5-yl)tetrahydro-1H-pyrrol-3-yl]benzamide
SB33-1193 Screening compound: N-[(3S,4R)-1-(4-methoxy-3-methylbenzyl)-4-(3-methyl-1H-1,2,4-triazol-5-yl)tetrahydro-1H-pyrrol-3-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound SB33-1193
N-[(3S,4R)-1-(4-methoxy-3-methylbenzyl)-4-(3-methyl-1H-1,2,4-triazol-5-yl)tetrahydro-1H-pyrrol-3-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SB33-1193

Molecular Formula

C23H27N5O2 (C23 H27 N5 O2)

Compound Name

N-[(3S,4R)-1-(4-methoxy-3-methylbenzyl)-4-(3-methyl-1H-1,2,4-triazol-5-yl)tetrahydro-1H-pyrrol-3-yl]benzamide

IUPAC name

N-[(3S4R)-1-[(4-methoxy-3-methylphenyl)methyl]-4-(3-methyl-1H-124-triazol-5-yl)pyrrolidin-3-yl]benzamide

SMILES

Cc1n[nH]c([C@@H](CN(Cc(cc2)cc(C)c2OC)C2)[C@H]2NC(c2ccccc2)=O)n1

InChI

InChI=1S/C23H27N5O2/c1-15-11-17(9-10-21(15)30-3)12-28-13-19(22-24-16(2)26-27-22)20(14-28)25-23(29)18-7-5-4-6-8-18/h4-11,19-20H,12-14H2,1-3H3,(H,25,29)(H,24,26,27)/t19-,20-/m0/s1

InChI Key

ZHPJNGVEWVKHQM-PMACEKPBSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

405.5

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.480

Distribution Coefficient, logD

1.543

Water Solubility, LogSw

-2.87

Polar Surface Area

69.569

Acid Dissociation Constant (pKa)

10.37

Base Dissociation Constant (pKb)

8.28

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

34.78

SB33-1193 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system

References: we are preparing a list of scientific research reports with SB33-1193 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SB33-1193?
Check Price and Availability of SB33-1193, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SB33-1193 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SB33-1193
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SB33-1193
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SB33-1193 available by request